Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koivunen

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Cancers|May 14, 2022
Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort StudySaara Kuusisalo, Jussi P Koivunen, Sanna Iivanainen
Annals of Medicine|March 17, 2025
Association of anti-PD-(L)1 treatment duration to efficacy in advanced solid tumors: a single center retrospective studySaara Kuusisalo, Sanna Iivanainen, Jussi P Koivunen
Anticancer Research|June 26, 2024
ALK Inhibitor and Chemotherapy Combinations in Models of ALK-Translocated NSCLCMilla E K Luukkainen, Jussi P Koivunen
BMC Cancer|December 25, 2012
Alternative dosing of dual PI3K and MEK inhibition in cancer therapyElina Jokinen, Niina Laurila, Jussi P Koivunen
The Journal of Biological Chemistry|February 26, 1999
Cloning of the alpha subunit of prolyl 4-hydroxylase from Drosophila and expression and characterization of the corresponding enzyme tetramer with some unique propertiesP Annunen, P Koivunen, K I Kivirikko
Journal of Cancer Research and Clinical Oncology|June 7, 2018
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patientsTiina Moilanen, Anna Jokimäki, Olli Tenhunen, et al.
International Journal of Oncology|June 29, 2017
HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLCTiia Honkanen, Emmi Wilenius, Peppi Koivunen, et al.
Clinical Otolaryngology and Allied Sciences|April 1, 1997
The growth rate of osteomas of the paranasal sinusesP Koivunen, H Löppönen, A P Fors, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 28, 2014
Predictive factors for quality of life after tonsillectomy among adults with recurrent pharyngitis: a prospective cohort studyT Koskenkorva, P Koivunen, E Läärä, et al.
International Journal of Cancer|September 29, 2011
A novel treatment strategy for EGFR mutant NSCLC with T790M-mediated acquired resistanceErika Taube, Elina Jokinen, Peppi Koivunen, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Cancers|May 14, 2022
Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort StudySaara Kuusisalo, Jussi P Koivunen, Sanna Iivanainen
Annals of Medicine|March 17, 2025
Association of anti-PD-(L)1 treatment duration to efficacy in advanced solid tumors: a single center retrospective studySaara Kuusisalo, Sanna Iivanainen, Jussi P Koivunen
Anticancer Research|June 26, 2024
ALK Inhibitor and Chemotherapy Combinations in Models of ALK-Translocated NSCLCMilla E K Luukkainen, Jussi P Koivunen
BMC Cancer|December 25, 2012
Alternative dosing of dual PI3K and MEK inhibition in cancer therapyElina Jokinen, Niina Laurila, Jussi P Koivunen
The Journal of Biological Chemistry|February 26, 1999
Cloning of the alpha subunit of prolyl 4-hydroxylase from Drosophila and expression and characterization of the corresponding enzyme tetramer with some unique propertiesP Annunen, P Koivunen, K I Kivirikko
Journal of Cancer Research and Clinical Oncology|June 7, 2018
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patientsTiina Moilanen, Anna Jokimäki, Olli Tenhunen, et al.
International Journal of Oncology|June 29, 2017
HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLCTiia Honkanen, Emmi Wilenius, Peppi Koivunen, et al.
Clinical Otolaryngology and Allied Sciences|April 1, 1997
The growth rate of osteomas of the paranasal sinusesP Koivunen, H Löppönen, A P Fors, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 28, 2014
Predictive factors for quality of life after tonsillectomy among adults with recurrent pharyngitis: a prospective cohort studyT Koskenkorva, P Koivunen, E Läärä, et al.
International Journal of Cancer|September 29, 2011
A novel treatment strategy for EGFR mutant NSCLC with T790M-mediated acquired resistanceErika Taube, Elina Jokinen, Peppi Koivunen, et al.
Pageof 8